Inventor · disambiguated record
Cristina Lopez-Lopez
Also filed as: LOPEZ-LOPEZ CRISTINA
5 granted patents·6 pending applications·1 citations·filing 2012–2022
65Inventor score
Top patents by PatentIndex Score
11 records- 0173US12215387B2Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2022·Granted Feb 4, 2025·0 cites·20 claims
- 0267US9828642B2Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2015·Granted Nov 28, 2017·1 cites·11 claims
- 0366US2022211679A1Alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0462US11359241B2Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2017·Granted Jun 14, 2022·0 cites·8 claims
- 0561US11311525B2Use of alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2017·Granted Apr 26, 2022·0 cites·9 claims
- 0653US2020345746A1Oxazine Derivative for Use in the Prevention of Alzheimer's Disease in at Risk PatentsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0750US2015313884A1Use of alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 0840US10722518B2Oxazine derivative for use in the treatment or prevention of cerebral amyloid angiopathyNOVARTIS AG·Filed 2017·Granted Jul 28, 2020·0 cites·17 claims
- 0940US2018036315A1Oxazine Derivative for Use in the Prevention of Alzheimer's Disease in at Risk PatientsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1035US2014171448A1Use of nicotinic acetylcholine receptor alpha 7 activatorsFEUERBACH DOMINIK·Filed 2012·Application pending·0 cites
- 1128US2014228398A1COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASEDI PAOLO THERESE·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →